Metropolitan Hospital Center is a hospital in East Harlem, New York City. It has been affiliated with New York Medical College since it was founded in 1875, representing the oldest partnership between a hospital and a private medical school in the United States.

During the past decade, Metropolitan Hosp. Ctr. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metropolitan Hosp. Ctr." #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 28 trials, followed by "International Maternal Pediatric Adolescent AIDS Clinical Trials Group" with 6 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 3 trials sponsored, "AIDS Clinical Trials Group" with 1 trials sponsored and "Cephalon" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metropolitan Hosp. Ctr." #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 20 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 7 trials as a collaborator, "Glaxo Wellcome" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Agency for Healthcare Research and Quality (AHRQ)" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Metropolitan Hosp. Ctr." are "HIV Infections" (32 trials), "HIV Infection" (2 trials), "Measles" (2 trials), "Pregnancy" (2 trials) and "Antibiotic Resistance" (1 trials). Many other conditions were trialed in "Metropolitan Hosp. Ctr." in a lesser frequency.

Most popular intervention types in "Metropolitan Hosp. Ctr." are "Drug" (27 trials), "Biological" (5 trials), "Behavioral" (4 trials), "Other" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Didanosine" (6 trials), "Nevirapine" (6 trials), "Ritonavir" (5 trials) and "Lamivudine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Metropolitan Hosp. Ctr." are 39 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Metropolitan Hosp. Ctr.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Metropolitan Hosp. Ctr., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Metropolitan Hosp. Ctr., 11 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 8 trials that are defined as “Not Applicable".